Efficacy of add-on therapy of aliskiren to an angiotensin II receptor blocker on renal outcomes in advanced-stage chronic kidney disease: a prospective, randomized, open-label study
Crossref DOI link: https://doi.org/10.1007/s10157-014-1044-4
Published Online: 2014-10-22
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Soji, Kotaro
Doi, Shigehiro
Nakashima, Ayumu
Sasaki, Kensuke
Kawai, Toru
Aoki, Asuka
Kyuden, Yasufumi
Fujiwara, Kenta
Yokoyama, Yukio
Masaki, Takao
Text and Data Mining valid from 2014-10-22